JANA Vol 9 #1 - American Nutraceutical Association

More documents

Recommendations

Info

24. Bellas RE, Lee JS, Sonenshein GE. Expression of a constitutive NF-kappa B-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells. J Clin Invest 1995;96:2521-2527. 25. American Heart Association, http://www.americanheart.org/presenter.jhtml?identifier=4677. 26. Ordovas JM, Corella D, Cupples LA, Demissie S, Kelleher A, Coltell O, Wilson PW, Schaefer EJ, Tucker K. Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: the Framingham Study. Am J Clin Nutr 2002 Jan;75(1):38-46. 27. Turpeinen AM, Basu S, Mutanen M. A high linoleic acid diet increases oxidative stress in vivo and affects nitric oxide metabolism in humans. Prostaglandins Leukot Essent Fatty Acids 1998;59:229-233. 28. Toborek M, Barger SW, Mattson MP, Barve S, McClain CJ, Hennig B. Linoleic acid and TNF-alpha cross-amplify oxidative injury and dysfunction of endothelial cells. J Lipid Res 1996;37:123-135. 29. European Commission Directorate General for Health and Consumer Protection. Eurodiet: Nutrition & Diet for Healthy Lifestyles in Europe, 2002. Available at: http://europa.eu. int/comm/health/ph_determinants/ life_style/nutrition/documents/ev_20030630_co03_ en.pdf. Accessed September 1, 2004. 30. World Health Organization. Diet, Nutrition and the Prevention of Chronic Diseases. Technical Report Series 916. Geneva: World Health Organization, 2002. Available at:http://www.who.int/hpr/NPH/docs/who_ fao_expert_report.pdf. Accessed September 1, 2004. 31. Hamazaki T, Okuyama H. The Japan Society for Lipid Nutrition recommends to reduce the intake of linoleic acid: a review and critique of the scientific evidence. World Rev Nutr Diet 2003;92:109-132. 32. International Society for the Study of Fatty Acids and Lipids (ISSFAL). Workshop on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. Available at http://www.issfal.org.uk/adequateintakes.htm. Accessed September 1, 2004. 33. Nie L, Wang J, Clark LT, Tang A, Vega GL, Grundy SM, Cohen JC. Body mass index and hepatic lipase gene (LIPC) polymorphism jointly influence postheparin plasma hepatic lipase activity. J Lipid Res 1998 May;39(5):1127-1130. 34. Ko YL, Hsu LA, Hsu KH, Ko YH, Lee YS. The interactive effects of hepatic lipase gene promoter polymorphisms with sex and obesity on high-density-lipoprotein cholesterol levels in Taiwanese-Chinese. Atherosclerosis 2004;172:135–142. 35. St-Pierre J, Miller-Felix I, Paradis ME, et al. Visceral obesity attenuates the effect of the hepatic lipase –514CT polymorphism on plasma HDL-cholesterol levels in French-Canadian men. Mol Genet Metab 2003;78:31–36. 36. Ordovas JM, Corella D, Demissie S, et al. Dietary fat intake determines the effect of a common polymorphism in the hepatic lipase gene promoter on high-density lipoprotein metabolism: evidence of a strong dose effect in this genenutrient interaction in the Framingham Study. Circulation 2002;106:2315–2321. 6 37. Tai ES, Corella D, Deurenberg-Yap M, et al. Dietary fat interacts with the –514CT polymorphism in the hepatic lipase gene promoter on plasma lipid profiles in a multiethnic Asian population: the 1998 Singapore National Health Survey. J Nutr 2003;133:3399–3408. 38. Witkin SS, Gerber S, Ledger WJ: Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis 2002;34:204-209. 39. Kastrati A, Koch W, Berger PB, Mehilli J, Stephenson K, Neumann FJ, von Beckerath N, Bottiger C, Duff GW, Schomig A. Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting. J Am Coll Cardiol 2000;36:2168-2173. 40. Francis SE, Camp NJ, Dewberry RM, Gunn J, Syrris P, Carter ND, Jeffery S, Kaski JC, Cumberland DC, Duff GW, Crossman DC. Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 1999;99:861-866. 41. Endres S, Ghorbani R, Kelley VE, Georgilis K, Lonnemann G, van der Meer JW, Cannon JG, Rogers TS, Klempner MS, Weber PC, et al. The effect of dietary supplementation with n- 3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989 Feb;320:265-271. 42. Varilek GW, Yang F, Lee EY, deVilliers WJ, Zhong J, Oz HS, Westberry KF, McClain CJ. Green tea polyphenol extract attenuates inflammation in interleukin-2-deficient mice, a model of autoimmunity. J Nutr 2001 Jul;131(7):2034-2039. JANA Vol. 9, No. 1, 2006
P E R S P E C T I V E A R T I C L E The Physiological and Psychological Effects of Animal Therapy: Examining the Healing Power of Animals JANA Vol. 9, No. 1, 2006 Niki Sepsas,* Associate Editor, Allen Montgomery, RPh, Managing Editor Journal of the American Nutraceutical Association Birmingham, Alabama Growing up with an affectionate, furry friend is a very satisfying childhood memory for many, as the love and care we bestowed on our pets was returned to us via their unconditional love and devotion. In recent years, however, a growing number of people have begun touting more than just the “warm and fuzzy” benefits of interacting with the animals in our lives. Medical practitioners, veterinarians, health care professionals, and others are pointing to the potential therapeutic value of this ancient bond between people and animals. In November 2005, the American Heart Association released the results of a clinical study that confirmed what many have suspected for years—interaction with pet therapy teams has a measurable positive effect on hospital patients. The results of the study, Animal Assisted Therapy and Heart Failure, 1 were presented at the American Heart Association’s “Scientific Sessions in Dallas” gathering. Researchers discovered that a 12-minute visit with “man’s best friend” helped heart and lung function by lowering pressure, diminishing release of harmful hormones, and decreasing anxiety among hospitalized heart failure patients. Benefits exceeded those that resulted from a visit with a human volunteer or from being left alone. The therapeutic approach of using dogs to soothe people’s minds and improve health has been considered more a “nicety” than credible science, according to Kathie M. * Corresondence: Niki Sepsas 1057 Sherbrooke Drive Birmingham, AL 35205 Phone: (205) 942-5335 Email: nikisepsas@bellsouth.net Cole, RN, MN, CCRN, a clinical nurse at the UCLA Medical Center in Los Angeles and lead author of the study. To provide clinical proof of the benefits of animal-assisted activities and therapy, researchers studied the reactions of 76 hospitalized heart failure patients to a visit from either a human and dog volunteer team, a human volunteer alone, or no visit (the at-rest group). During the 12-minute intervention with the volunteer/dog team group, specially trained dogs would lie on patients’ beds so they could touch them while interacting with the volunteer/dog team. Researchers monitored patients’ homodynamics – the collective system of measurement for blood volume, heart function, and resistance of the blood vessels. Investigators also measured epinephrine and norepinephrine levels at three time periods, before, during, and after the interaction, and administered an anxiety test before and after as well. Researchers found that anxiety scores dropped 24 percent for participants who received a visit from the volunteer/dog team. Scores for the volunteer-only group dropped 10 percent while the at-rest group’s score did not change. Levels of the stress hormone epinephrine decreased an average of 14.1 picograms/wL, or 17 percent, in the volunteer/dog team group; 2 percent in the volunteer-only group; and rose an average of 7 percent in the at-rest group. The pulmonary capillary wedge, a measurement of left atrial pressure, dropped an average of 10 percent at the end of the interaction for those receiving volunteer/dog team therapy. It increased 3 percent for the volunteer-only group, and increased 5 percent for the at-rest group. Systolic pulmonary pressure, a measure of pressure in the lungs, dropped 5 percent during and 5 percent after therapy in the volunteer/dog team group. It rose during and after therapy in the other two groups. 7
Page 1 and 2: The Journal of the American Nutrace
Page 3 and 4: Decipher the Latest Bombshell Nutri
Page 5 and 6: ORDER THE ENTIRE SET…OR INDIVIDUA
Page 7 and 8: P E R S P E C T I V E A R T I C L E
Page 9 and 10: understanding of the interactions b
Page 11: • Genetics: the study of the patt
Page 15 and 16: took certain of the shelter’s ani
Page 17 and 18: were in a cast,” Williams explain
Page 19 and 20: R E V I E W A R T I C L E Microdose
Page 21 and 22: 3. Generation of Beneficial Immune
Page 23 and 24: There were 37 patients (randomized
Page 25 and 26: tion and/or severity of cold sympto
Page 27 and 28: 70. Gangloff SC, Guenounou M. Toll-
Page 29 and 30: C L I N I C A L R E S E A R C H JAN
Page 31 and 32: Table 2. Pregnancy outcomes od, 83%
Page 33 and 34: REFERENCES 1. American College of O
Page 35 and 36: complications such as microvascular
Page 37 and 38: and reported exercising for 30 minu
Page 39 and 40: In the current study, changes in th
Page 41: ��

JANA Vol 9 #1 - American Nutraceutical Association

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?